CERO: Cero Therapeutics Holdings Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Cero Therapeutics Holdings Inc (CERO).

OverviewDividends

$9.02M Market Cap.

As of 06/13/2025 5:00 PM ET (MRY) • Disclaimer

CERO Market Cap. (MRY)


CERO Shares Outstanding (MRY)


CERO Assets (MRY)


Total Assets

$6.21M

Total Liabilities

$8.10M

Total Investments

$0

CERO Income (MRY)


Revenue

$0

Net Income

-$7.73M

Operating Expense

$15.30M

CERO Cash Flow (MRY)


CF Operations

-$12.28M

CF Investing

$0

CF Financing

$13.73M

CERO Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$6,206,929 (21.08%)

$5,126,302 (-54.83%)

$11,349,488 (-53.05%)

$24,175,570

Assets Current

$3,714,041 (88.53%)

$1,970,035 (-72.16%)

$7,076,023 (-63.76%)

$19,523,528

Assets Non-Current

$2,492,888 (-21.02%)

$3,156,267 (-26.14%)

$4,273,465 (-8.14%)

$4,652,042

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0

Shareholders Equity

-$1,894,563 (95.50%)

-$42,057,695 (-20.61%)

-$34,870,780 (-48.84%)

-$23,428,359

Property Plant & Equipment Net

$1,992,888 (-36.86%)

$3,156,267 (-26.14%)

$4,273,465 (-8.14%)

$4,652,042

Cash & Equivalents

$3,327,060 (107.78%)

$1,601,255 (-76.52%)

$6,819,564 (-64.51%)

$19,217,482

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0

Trade & Non-Trade Payables

$4,507,318 (169.62%)

$1,671,745 (327.35%)

$391,185 (-14.94%)

$459,919

Accumulated Retained Earnings (Deficit)

-$70,917,853 (-64.58%)

-$43,089,821 (-20.36%)

-$35,800,244 (-49.35%)

-$23,971,128

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0

Total Debt

$1,575,499 (-46.49%)

$2,944,283 (-2.41%)

$3,016,964 (-16.25%)

$3,602,214

Debt Current

$876,392 (-35.97%)

$1,368,784 (103.57%)

$672,374 (14.89%)

$585,250

Debt Non-Current

$699,107 (-55.63%)

$1,575,499 (-32.80%)

$2,344,590 (-22.29%)

$3,016,964

Total Liabilities

$8,101,492 (59.39%)

$5,082,653 (23.40%)

$4,118,924 (-25.15%)

$5,502,585

Liabilities Current

$7,402,385 (111.07%)

$3,507,154 (201.31%)

$1,163,953 (-36.68%)

$1,838,248

Liabilities Non-Current

$699,107 (-55.63%)

$1,575,499 (-46.68%)

$2,954,971 (-19.36%)

$3,664,337

CERO Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0

Selling General & Administrative Expense

$8,985,351 (276.51%)

$2,386,469 (12.27%)

$2,125,628 (-14.27%)

$2,479,447

Research & Development Expense

$6,315,552 (19.42%)

$5,288,580 (-46.28%)

$9,845,603 (7.76%)

$9,136,884

Operating Expenses

$15,300,903 (99.36%)

$7,675,049 (-35.89%)

$11,971,231 (3.06%)

$11,616,331

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0

Consolidated Income

-$7,732,212 (-6.07%)

-$7,289,577 (38.38%)

-$11,829,116 (-11.28%)

-$10,629,620

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Income

-$7,732,212 (-6.07%)

-$7,289,577 (38.38%)

-$11,829,116 (-11.28%)

-$10,629,620

Preferred Dividends Income Statement Impact

$2,784,839 (0%)

$0 (0%)

$0 (0%)

$0

Net Income Common Stock

-$10,517,051 (-44.28%)

-$7,289,577 (38.38%)

-$11,829,116 (-11.28%)

-$10,629,620

Weighted Average Shares

$28,972 (9821.92%)

$292 (-93.49%)

$4,487 (-0.09%)

$4,491

Weighted Average Shares Diluted

$28,972 (9821.92%)

$292 (-93.49%)

$4,487 (-0.09%)

$4,491

Earning Before Interest & Taxes (EBIT)

-$7,732,212 (-6.07%)

-$7,289,577 (38.38%)

-$11,829,116 (-11.28%)

-$10,629,620

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0

Operating Income

-$15,300,903 (-99.36%)

-$7,675,049 (35.89%)

-$11,971,231 (-3.06%)

-$11,616,331

CERO Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$0 (0%)

$0 (0%)

-$694,232 (-13.33%)

-$612,566

Net Cash Flow from Financing

$13,727,634 (2301.29%)

$571,678 (10063.16%)

$5,625 (-90.66%)

$60,255

Net Cash Flow from Operations

-$12,278,569 (-112.07%)

-$5,789,987 (50.55%)

-$11,709,311 (-16.00%)

-$10,094,380

Net Cash Flow / Change in Cash & Cash Equivalents

$1,449,065 (127.77%)

-$5,218,309 (57.91%)

-$12,397,918 (-16.45%)

-$10,646,691

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0

Capital Expenditure

$0 (0%)

$0 (0%)

-$694,232 (-13.33%)

-$612,566

Issuance (Repayment) of Debt Securities

-$446 (-100.07%)

$605,230 (0%)

$0 (0%)

$0

Issuance (Purchase) of Equity Shares

$4,809,703 (62845.99%)

$7,641 (35.84%)

$5,625 (-90.66%)

$60,255

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0

Share Based Compensation

$924,668 (854.29%)

$96,896 (-74.57%)

$381,070 (32.44%)

$287,735

Depreciation Amortization & Accretion

$1,010,164 (-9.58%)

$1,117,198 (4.14%)

$1,072,809 (45.87%)

$735,473

CERO Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

348.90% (1187.45%)

27.10% (-65.57%)

78.70%

-

Return on Average Assets (ROAA)

-144.50% (-97.67%)

-73.10% (-750.00%)

-8.60%

-

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

206.50% (306.50%)

-100.00% (-1049.43%)

-8.70%

-

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-0.33 (62.43%)

-0.88 (88.68%)

-7.78 (7.35%)

-8.4

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

-4.76 (-191.31%)

-1.63 (75.86%)

-6.77 (30.37%)

-9.72

Debt to Equity Ratio (D/E)

-4.28 (-3433.88%)

-0.12 (-2.54%)

-0.12 (49.79%)

-0.23

Earnings Per Share (EPS)

-363 (98.55%)

-24,972.8 (-845.94%)

-2,640 (-11.86%)

-2,360

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0

Free Cash Flow Per Share (FCFPS)

-423.81 (97.86%)

-19,835.52 (-617.57%)

-2,764.25 (-15.94%)

-2,384.16

Book Value Per Share (BVPS)

-65.39 (99.95%)

-144,082.55 (-1754.03%)

-7,771.3 (-48.96%)

-5,216.89

Tangible Assets Book Value Per Share (TABVPS)

214.24 (-98.78%)

17,561.84 (594.32%)

2,529.35 (-53.01%)

5,383.27

Enterprise Value Over EBIT (EV/EBIT)

-1 (90.00%)

-10 (50.00%)

-20 (4.76%)

-21

Enterprise Value Over EBITDA (EV/EBITDA)

-1.11 (90.24%)

-11.34 (48.22%)

-21.9 (4.87%)

-23.02

Asset Turnover

0 (0%)

0 (0%)

0

-

Current Ratio

0.5 (-10.68%)

0.56 (-90.76%)

6.08 (-42.76%)

10.62

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0

Free Cash Flow (FCF)

-$12,278,569 (-112.07%)

-$5,789,987 (53.32%)

-$12,403,543 (-15.85%)

-$10,706,946

Enterprise Value (EV)

$7,443,372 (-89.36%)

$69,984,274 (-70.28%)

$235,516,417 (3.41%)

$227,744,188

Earnings Before Tax (EBT)

-$7,732,212 (-6.07%)

-$7,289,577 (38.38%)

-$11,829,116 (-11.28%)

-$10,629,620

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$6,722,048 (-8.91%)

-$6,172,379 (42.62%)

-$10,756,307 (-8.71%)

-$9,894,147

Invested Capital

-$2,947,017 (-199.49%)

$2,962,176 (-53.59%)

$6,382,935 (-5.04%)

$6,722,054

Working Capital

-$3,688,344 (-139.95%)

-$1,537,119 (-126.00%)

$5,912,070 (-66.57%)

$17,685,280

Tangible Asset Value

$6,206,929 (21.08%)

$5,126,302 (-54.83%)

$11,349,488 (-53.05%)

$24,175,570

Market Capitalization

$9,018,754 (-86.87%)

$68,708,288 (-70.89%)

$236,024,332 (3.64%)

$227,744,188

Average Equity

-$3,014,488 (88.81%)

-$26,934,560 (-79.16%)

-$15,033,818

-

Average Assets

$7,280,587 (-26.98%)

$9,971,137 (-92.77%)

$137,825,525

-

Invested Capital Average

-$3,743,814 (-151.36%)

$7,289,940 (-94.63%)

$135,799,636

-

Shares

75,156 (2306.53%)

3,123 (-72.82%)

11,491 (0.00%)

11,491